Faculty Opinions recommendation of SUMO2 and SUMO3 redundantly prevent a noncanonical type I interferon response.
Year: 2018
Type: peer-review
Author: Howard Young
Institutions: National Institutes of Health, National Cancer Institute
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4255419231
